Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,248 across all filing types
Latest filing 2019-02-09 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Reply to Clarification Sought
Regulatory Filings Classification · 90% confidence The document is a letter addressed to the National Stock Exchange Limited regarding a clarification sought about a previous announcement related to the outcome of a board meeting. The main content is about the appointment of BDO India LLP as the Internal Auditor of the company, including a brief profile of the auditor firm. There are no financial statements, detailed audit results, or comprehensive audit opinions presented. The document is relatively short (2878 characters) and serves as an announcement or clarification rather than a full audit report or annual report. It does not contain financial data or detailed audit findings, so it is not an Audit Report (AR) or Annual Report (10-K). It is also not a regulatory certification or officer attestation. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories.
2019-02-09 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation on Company's performance for the quarter and nine months ended December 31, 2018." It contains detailed financial data including quarterly and nine-month standalone and consolidated income statements, operational highlights, and historical financials. The presence of detailed financial metrics, operational commentary, and presentation format indicates this is a presentation document intended for investors. It is not a full annual report, audit report, or earnings release summary but a detailed presentation of quarterly and nine-month results. Therefore, the document fits the category of an Investor Presentation (IP). The document length is substantial (15,000 characters), and it contains actual financial data and analysis, confirming it is not merely an announcement or certification.
2019-02-01 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is titled as a newspaper advertisement of unaudited financial results for the quarter and nine months ended December 31, 2018. It references Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates publication of financial results in newspapers. The document contains extracts of unaudited standalone and consolidated financial results, including figures for the quarter and nine months ended December 31, 2018, and references to the full format of the financial results filed with stock exchanges. The document is not a full annual report or audit report but a public disclosure of quarterly unaudited financial results. This fits the definition of an Interim / Quarterly Report (IR) as it contains substantive financial data for a period shorter than a full fiscal year and is not merely an announcement or certification. The document length (15,000 characters) and content confirm it is a report, not just an announcement. Therefore, the appropriate classification is IR.
2019-01-31 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication from Bliss GVS Pharma Ltd. to stock exchanges (NSE and BSE) dated January 29, 2019. It announces the outcome of a Board Meeting held on the same day. The key content includes approval of unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2018, along with the Limited Review Report of the auditors. It also mentions appointment of an internal auditor and deferral of a decision on the Employee Stock Option Plan. The document contains detailed financial data tables for the specified periods, including revenues, expenses, and profit/loss figures. The presence of unaudited financial results for a quarter and nine months period, along with detailed financial data, indicates this is an Interim / Quarterly Report. The document is not merely an announcement of a report but includes substantive financial data and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2019-01-30 English
Financial Result Updates
Regulatory Filings
2019-01-29 English
Updates
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled for January 29, 2019, published as a newspaper advertisement. It mentions the agenda to consider and approve the unaudited standalone and consolidated financial results for the quarter ended December 31, 2018, and a proposal for an Employee Stock Option Plan. The document is a formal announcement pursuant to SEBI regulations about the upcoming Board Meeting and related trading window closure. It does not contain the actual financial results or detailed report but only the notice of the meeting where such results will be considered. Therefore, this document is an announcement of a Board Meeting notice, not the financial report itself or detailed management discussion. The appropriate classification is Regulatory Filings (RNS) as it is a regulatory announcement notice that does not fit other specific categories like Interim Report or Management Reports.
2019-01-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.